The relentless pursuit of novel therapeutics in drug discovery hinges on the availability of versatile and reactive chemical building blocks. 4,6-Dichloro-2-(methylsulfonyl)pyrimidine, identified by CAS 4489-34-3, has emerged as a compound of significant importance in this field. Its unique heterocyclic structure makes it an invaluable intermediate for synthesizing a wide array of biologically active molecules.

As a key pharmaceutical intermediate, 4,6-Dichloro-2-(methylsulfonyl)pyrimidine offers chemists multiple points for functionalization. The chlorine atoms at the 4 and 6 positions are susceptible to nucleophilic substitution reactions, while the methylsulfonyl group can influence electronic properties and participate in various transformations. This inherent reactivity allows for the precise construction of complex molecular architectures that are often the basis of new drug candidates. Researchers often seek to buy this compound to explore these synthetic possibilities, aiming to develop treatments for various diseases.


NINGBO INNO PHARMCHEM CO.,LTD., a leading chemical supplier and manufacturer based in China, plays a vital role in facilitating drug discovery research by providing high-purity 4,6-Dichloro-2-(methylsulfonyl)pyrimidine. Our commitment to quality ensures that scientists receive a reliable starting material, crucial for the successful development of potential new drugs. The competitive price and consistent availability from our facilities support the continuous progression of research projects.


The impact of this pyrimidine derivative extends to the creation of kinase inhibitors, a class of drugs widely used in cancer therapy. Its structural elements can be tailored to achieve specific binding affinities and pharmacological profiles. For organizations involved in pharmaceutical R&D, sourcing this critical intermediate from a reputable manufacturer like NINGBO INNO PHARMCHEM CO.,LTD. is a strategic advantage. We empower drug discovery by providing the essential chemical tools needed for innovation.